Artificial Pancreas Device Systems Market Size | CAGR of 19.1%

<h2>Market Overview</h2>
<p>The Global <strong>Artificial Pancreas Device Systems Market</strong> size is expected to be worth around <strong>USD 1417.2 Million</strong> by 2033 from <strong>USD 246.8 Million</strong> in 2023, growing at a CAGR of <strong>19.1%</strong> during the forecast period from 2024 to 2033.</p>
<p>Artificial pancreas device systems closely replicate the functions of a healthy pancreas in terms of glucose regulation. These artificial devices not only monitor body glucose levels but can also autonomously fine-tune insulin distribution, mitigating high levels while simultaneously decreasing low ones – according to FDA, using artificial pancreases leads to more effective blood sugar level management among individuals living with type 1 diabetes than using conventional treatments alone.</p>
<p>This report tracks market development through current trends, historical growth analysis and revenue projections up to 2023. Furthermore, this report spotlights Control to Range (CTR) Systems and Control to Target (CTT) Systems within the market; furthermore placing special attention on end user segments such as hospitals and medical centers while offering in-depth analyses for each one of them. Furthermore, market dynamics such as pricing feasibility analyses as well as macroeconomic and feasibility indicators are thoroughly explored in order to provide a complete forecast for artificial pancreas device system sales market.</p>
<p>Industry growth is driven by the rising prevalence of diabetes and intensive R&amp;D efforts made by industry players. Artificial pancreas devices (APDS), which control blood glucose levels in diabetic patients, are being researched extensively by industry players. These devices are much more accessible and are widely accepted by patients. Major factors driving the growth of this market include the growing geriatric population and the rising incidence of diabetes.</p>
<p><img class="alignnone size-full wp-image-111494" src="https://market.us/wp-content/uploads/2022/07/Artificial-Pancreas-Device-Systems-Market-Size.png" alt="Artificial Pancreas Device Systems Market Size" width="1225" height="745"></p>

<h2>市场概述</h2>
<p>全球人工胰腺设备系统市场规模预计到2033年将达到约141.72亿美元，从2023年的2.468亿美元增长，在2024年至2033年预测期间以19.1%的复合年增长率增长。</p>
<p>人工胰腺设备系统在调节血糖方面与正常胰腺的功能极为相似。这些人工设备不仅能够监测体内血糖水平，还能自主微调胰岛素的分配，降低高血糖水平的同时，降低低血糖水平——根据美国食品药品监督管理局（FDA）的数据，使用人工胰腺相较于单纯使用传统治疗方法，在管理1型糖尿病患者的血糖水平方面更为有效。</p>
<p>本报告通过当前趋势、历史增长分析和至2023年的收入预测来追踪市场发展。此外，本报告还聚焦于市场中的控制范围（CTR）系统和控制目标（CTT）系统；进一步地，对终端用户群体，如医院和医疗中心进行深入分析，并为每一个群体提供详细分析。此外，本报告还对市场动态进行了全面探讨，包括定价可行性分析、宏观经济指标和可行性指标，以提供人工胰腺设备系统销售市场的完整预测。</p>
<p>行业增长动力来自于糖尿病患病率的上升以及行业参与者的大力研发投入。人工胰腺设备（APDS），用于控制糖尿病患者血糖水平，正受到行业参与者的广泛研究。这些设备易于获取且患者普遍接受。推动市场增长的主要因素包括人口老龄化加剧和糖尿病发病率的上升。</p>
<p><img class=